Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates on April 23, 2026
Vivoryon Therapeutics N.V. to Report Full Year 2025 Financial Results and Business Updates…
BioVersys to Present Data on Clinical and Preclinical Pipeline Programs at ESCMID Global 2026
April 15, 2026 01:00 ET | Source: BioVersys BASEL, Switzerland, April 15,…
Revolution Medicines, Inc. Prices $2.0 Billion in Concurrent Upsized Offerings of Common Stock and Convertible Senior Notes
REDWOOD CITY, Calif., April 15, 2026 (GLOBE NEWSWIRE) -- Revolution Medicines, a…
The Missing Piece of Hybrid AI: Saltire Software Turns Plain English Into Interactive Geometry
PORTLAND, Ore., April 14, 2026 (GLOBE NEWSWIRE) -- As AI draws new…
Jama Connect Named Best Requirements Management Software for 2026 in G2’s Spring Grid Report
Jama Connect once again recognized as the best requirements management software by…
TRUEiGTECH Launches Prediction Market Platform Aggregated API, Connecting Polymarket, Kalshi and Many More
NEW YORK, April 14, 2026 (GLOBE NEWSWIRE) -- TRUEiGTECH today announced the…
Nxera Pharmas QUVIVIQ (daridorexant) 25mg and 50mg Receives Approval in Taiwan for the Treatment of Insomnia
Nxera’s partner Holling Bio-Pharma Corp. will commercialize QUVIVIQ® in Taiwan, a market with…
Transactions in connection with share buy-back program
Company announcement no. 10 - 2614 April 2026 Transactions in connection with…
Asgard Therapeutics appoints Professor Dr Wolfram Brugger as Chief Medical Officer as it advances transformative personalized off-the-shelf immunotherapy toward clinical development
April 14, 2026 03:30 ET | Source: Asgard Therapeutics Medical oncologist (ex…
Folks Unveils Survey Revealing 70% of HR Time in Canadian SMBs Spent on Administrative Tasks
The 2026 State of HR Survey Highlights the Need for Streamlined HR…
